A new white paper has explored the misuse of certain intellectual property (IP) tools that block generic and biosimilar medicines for the first time since the f 6 November 2020
Jonathan Roses, counsel Wolf, Greenfield & Sacks and Matthew Birkett, partner, Hoffmann Eitle, provide an Expert View on general treatment of salt and polymorph 23 October 2020
Denmark’s Genmab saw its shares drop over a tenth after it emerged the firm was locked in a legal battle over royalties for cancer drug daratumumab. 23 September 2020
An Expert View from Jonathan Roses (pictured, left), counsel, Wolf, Greenfield & Sacks, and Matthew Birkett, partner, Hoffmann Eitle, on the granting of two pat 22 September 2020
Canada-based Bausch Health Companies and its gastroenterology business, Salix Pharmaceuticals, have agreed to resolve a set of outstanding intellectual property 22 September 2020
US authorities have been urged to review whether Moderna Therapeutics has been upfront about public sources of funding for some of its work. 4 September 2020
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.